Grading Evaluation of Cardiotoxicity in Patients with Breast Cancer Treated with Adjuvant Paclitaxel Anthracycline/Cyclophosphamide Chemotherapy: A Meta-Analysis

OBJECTIVE: The cardiac safety of concurrent treatment with anthracycline (A), cyclophosphamide (C), and paclitaxel (T) in an adjuvant BC treatment regimen is still under debate. In this study, we aimed to determine cardiotoxicity events following ACT chemotherapy among operable breast cancer patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Weibao, Song, Mengli, Li, Linfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377951/
https://www.ncbi.nlm.nih.gov/pubmed/35979049
http://dx.doi.org/10.1155/2022/7963146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377951/
https://www.ncbi.nlm.nih.gov/pubmed/35979049
http://dx.doi.org/10.1155/2022/7963146

Ejemplares similares